Objective Biotechnology, Inc.
Publicly observedMinneapolis, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Minneapolis | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Objective Biotechnology, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | GN5KBQRNCBA9 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant11 Sept 2026Publicly observed
NIH SBIR/STTR award: Bionic Imaging Platform (BIP) for high performance functional imaging in freely navigating rodents
USD 479,794.00 · National Institute of Neurological Disorders and Stroke · Source: NIH RePORTER (opens in a new tab)
- Grant15 Sept 2025Publicly observed
NIH SBIR/STTR award: High performance miniaturized microscopes for through skull cortex-wide imaging in freely behaving mice
USD 386,174.00 · NIH Office of the Director · Source: NIH RePORTER (opens in a new tab)
- Grant15 Sept 2025Publicly observed
NIH SBIR/STTR award: High performance miniaturized microscopes for through skull cortex-wide imaging in freely behaving mice
USD 416,925.00 · NIH Office of the Director · Source: NIH RePORTER (opens in a new tab)
- Grant1 Sept 2024Publicly observed
NIH SBIR/STTR award: A computer-vision guided automated microinjection system with increased robustness, throughput, and generalizability to diverse species
USD 1,200,472.00 · NIH Office of the Director · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.